Zepbound Outperforms Wegovy in Weight Loss Study
Eli Lilly’s weight loss drug Zepbound has shown better results than rival Novo Nordisk’s Wegovy, with patients taking Zepbound losing an average of 20% of their weight compared to 14% for Wegovy. The study monitored 751 people and found that more patients on Zepbound achieved at least a 25% weight loss. This news is expected … Read more